Implications of LDL Subclass B in Patients at Cardiovascular Risk

被引:2
|
作者
Moredich, Cheryl [1 ]
Kark, Deborah [1 ]
Keresztes, Patricia [1 ]
机构
[1] Purdue Univ Calumet, Sch Nursing, Nursing, Hammond, IN 46323 USA
来源
NURSE PRACTITIONER | 2005年 / 30卷 / 07期
关键词
D O I
10.1097/00006205-200507000-00004
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
[No abstract available]
引用
收藏
页码:16 / 29
页数:7
相关论文
共 50 条
  • [21] LDL SUBCLASS PHENOTYPES AND THE RISK-FACTORS OF THE INSULIN-RESISTANCE SYNDROME
    AUSTIN, MA
    SELBY, JV
    INTERNATIONAL JOURNAL OF OBESITY, 1995, 19 : S22 - S26
  • [22] Electronegative LDL: a useful biomarker of cardiovascular risk?
    Luis Sanchez-Quesada, Jose
    Estruch, Montserrat
    Benitez, Sonia
    Ordonez-Llanos, Jordi
    CLINICAL LIPIDOLOGY, 2012, 7 (03) : 345 - 359
  • [23] Are LDL subclass measurements clinically relevant?
    Evan A Stein
    Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 : 120 - 121
  • [24] Are LDL subclass measurements clinically relevant?
    Stein, EA
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (03): : 120 - 121
  • [26] Atorvastatin Therapy in Practice- LDL Values in Patients with very high Cardiovascular Risk
    Laufs, Ulrich
    Jannowitz, Christina
    Pittrow, David
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (16) : 1249 - 1252
  • [27] Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk
    Ulrich Laufs
    Barbara Karmann
    David Pittrow
    Clinical Research in Cardiology, 2016, 105 : 783 - 790
  • [28] A NEW METHOD TO DETERMINE THE MODIFIED LDL ATHEROGENICITY AMONG PATIENTS AT LOW CARDIOVASCULAR RISK
    Eliashevich, Sofia
    Drapkina, Oxana
    Shoibonov, Batogab
    ATHEROSCLEROSIS, 2017, 263 : E200 - E200
  • [29] A study on serum homocysteine and oxidized LDL as markers of cardiovascular risk in patients with overt hypothyroidism
    Singh, Naveen Kumar
    Suri, Arpita
    Kumari, Mithlesh
    Kaushik, Priya
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2022, 43 (03) : 329 - 335
  • [30] Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk
    Laufs, Ulrich
    Karmann, Barbara
    Pittrow, David
    CLINICAL RESEARCH IN CARDIOLOGY, 2016, 105 (09) : 783 - 790